Isoniazid-Loaded Nano-Embedded Microparticles: Development, Optimization, and Physicochemical Characterization
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis , with high global incidence and significant mortality. Isoniazid (ISN) is a first-line antituberculosis drug whose low permeability and rapid elimination may limit its efficacy. Building upon our previous work on ISN-loaded poly(lactic-co-glycolic acid)-chitosan polymeric nanoparticles (ISN-PLGA-CHI-PNs), the present study aimed to develop and optimize nano-embedded microparticles (NeMs) using spray drying and a Box-Behnken experimental design. The ISN-PLGA-CHI-PNs were incorporated into a lactose matrix, and the resulting ISN-NeMs were evaluated for redispersibility, colloidal stability, and physicochemical properties. The original PNs exhibited a particle size of 230 ± 0.70 nm, a positive zeta potential of 27.4 ± 0.26 mV, and physical stability over 150 days at 4 °C. Nanoparticle mucin interaction and cellular internalization by J774 macrophages were also observed. Following spray drying, the ISN-NeMs exhibited spherical morphology, geometric particle sizes ranging from 1 to 4 μm, and a moisture content of 4.86%. The experimentally selected formulation achieved a redispersion index of 0.95, with recovery of the nanoscale characteristics of the embedded PNs and preservation of colloidal stability after redispersion. These findings demonstrate the feasibility of converting ISN-loaded nanoparticle suspensions into dry, redispersible microparticulate formulations while maintaining their main physicochemical characteristics.
Authors
- Fábio Rocha Formiga (ORCID: https://orcid.org/0000-0003-1553-0533)
- Joandra Maísa da Silva Leite (ORCID: https://orcid.org/0000-0003-3647-7081)
- José Lamartine Soares‐Sobrinho (ORCID: https://orcid.org/0000-0002-3280-0294)
- Diogo Rodrigo Magalhães Moreira (ORCID: https://orcid.org/0000-0003-3323-4404)
- Thayse Silva Medeiros (ORCID: https://orcid.org/0000-0002-8069-5871)
- Mônica Felts de La Roca Soares (ORCID: https://orcid.org/0000-0002-4873-915X)
- Lucas Marinho de Santana (ORCID: https://orcid.org/0009-0001-1664-4949)
- Douglas Dourado (ORCID: https://orcid.org/0000-0003-3445-5217)
- Marina Luiza Rocha Silva (ORCID: https://orcid.org/0000-0003-0229-4658)
Institutions
- Universidade Federal de Pernambuco (BR)
- Instituto Gonçalo Moniz (BR)
- Fundação Oswaldo Cruz (BR)
- Universidade de Pernambuco (BR)
Publication Details
- Journal
- Journal of Pharmaceutical Innovation
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1007/s12247-026-11150-4
- Primary Topic
- Advanced Drug Delivery Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00